APA (7th ed.) Citation

W, K., M, Z., F, E., AA, S., D, L., Y, A., . . . L, F. (2022). Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis. Anti-cancer drugs, 33(1), e738. https://doi.org/10.1097/CAD.0000000000001162

Chicago Style (17th ed.) Citation

W, Kian, et al. "Intravenous Immunoglobulin Efficacy on Pembrolizumab Induced Severe Toxic Epidermal Necrolysis." Anti-cancer Drugs 33, no. 1 (2022): e738. https://doi.org/10.1097/CAD.0000000000001162.

MLA (9th ed.) Citation

W, Kian, et al. "Intravenous Immunoglobulin Efficacy on Pembrolizumab Induced Severe Toxic Epidermal Necrolysis." Anti-cancer Drugs, vol. 33, no. 1, 2022, p. e738, https://doi.org/10.1097/CAD.0000000000001162.